Dr. Stephen Michael Karlovits, MD

Dr. Karlovits practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Dr. Karlovits' NPI, 1790786747, was assigned on August 2, 2005. Dr. Karlovits graduated from University Of Cincinnati College Of Medicine in 1993. Dr. Karlovits holds Pennsylvania license MD069586L.

Dr. Karlovits' primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Dr. Karlovits' primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dr. Karlovits is also affiliated with West Penn Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Karlovits to 3 more hospitals and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karlovits practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Karlovits' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Karlovits is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Karlovits' licenses on file in 2 states: Pennsylvania and Ohio.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Karlovits treats.

CMS data shows 641 Medicare services from Dr. Karlovits across 13 procedure codes in 2024, for 192 Medicare patients. Medicare paid $41,255 for them.

CMS counts 192 Medicare patients who saw Dr. Karlovits in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karlovits' median patient age at 71, with 48% women.

In 2024, Dr. Karlovits wrote 97 Medicare Part D claims for 55 patients. 91% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $314 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Karlovits for performance year 2024, reported through an alternative payment model (APM). Dr. Karlovits accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karlovits as offering telehealth.

Dmand AI links 30 papers to Dr. Karlovits, published from 2010 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Brain Neoplasms, Radiosurgery and Glioma. Dr. Karlovits has published most often in J Neurooncol. Dr. Karlovits' most frequent co-authors are Rodney Ervin Wegner, MD, Alexander K. Yu, MD and Zachary Horne, MD.

Dmand AI links Dr. Karlovits to 3 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Brain Neoplasms, Gliosarcoma and Oligodendroglioma.

CMS Open Payments shows 39 general payments to Dr. Karlovits from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 64% of the total. Elekta, Inc. paid the most, $1,206.

Dr. Karlovits graduated from University Of Cincinnati College Of Medicine in 1993.

Dr. Karlovits is in network with 17 carriers, including Elevance, Aetna and Highmark. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.